NORMAN, OKLA. – Eight proposals have been funded by the Strategic Equipment Investment Program from the Office of the Vice President for Research and Partnerships. Equipment purchased under this program is expected to advance research and creative activities at the University of Oklahoma.
This program supports the purchase of strategic equipment that enhances a team’s capabilities and competitiveness at a national level, specifically, the equipment is expected to “provide new opportunities for advancing the team’s ability to achieve new goals in terms of creativity, discovery, innovation, and competitiveness in securing external funding.”
The funded proposals are:
This is the seventh offering of the Strategic Equipment Investment Program. Proposals from Spring 2024 SEIP initiatives accounted for $4.5 million in new extramural funding. Learn more about SEIP and other internal seed funding opportunities at ou.edu/research.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
Doris Benbrook, Ph.D., a Presbyterian Health Foundation Presidential Professor at the University of Oklahoma College of Medicine, has been named Associate Director for Translational Research at OU Health Stephenson Cancer Center, the only National Cancer Institute-Designated Cancer Center in Oklahoma.
The Harold Hamm Diabetes Center at the University of Oklahoma Health Sciences will gain a new deputy director, Matthew Potthoff, Ph.D., effective January 1. Potthoff will also hold the title of Harold Hamm Endowed Chair in Clinical Diabetes Research and professor of biochemistry and physiology, with a secondary appointment in the division of neurology in the OU School of Medicine.
James George, M.D., and Jennifer Holter-Chakrabarty, M.D., were recognized by the American Society of Hematology (ASH) during its annual meeting Dec. 7-10.